Solubility-dependent complexation of active pharmaceutical ingredients with trimethyl-β-cyclodextrin under supercritical fluid condition

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 57, Issue 1-4, 2007, Pages 289-295

  Moribe, Kunikazu ^a   Fujito, Takayuki ^a   Tozuka, Yuichi ^a   Yamamoto, Keiji ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Active pharmaceutical ingredient; Cyclodextrin; Inclusion complex; Supercritical carbon dioxide

Indexed keywords

EID: 34047151188     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-006-9175-1     Document Type: Conference Paper

References (17)

1. 2. Food Res. Int. 38, 1009-1014 (2005).
2. Peng, J., Fan, G., Wu, Y.: Supercritical fluid extraction of aurentiamide acetate from Patrinia villosa Juss and subsequent isolation by silica gel and high-speed countercurrent chromatography. J. Chromatogr. A 1083, 52-57 (2005).
3. Braga, M.E.M., Ehlert, P.A.D., Ming, L.C., Meireles, M.A.A.: Supercritical fluid extraction from Lippia alba: global yields, kinetic data, and extract chemical composition. J. Supercrit. Fluid 34, 149-156 (2005).
4. Perrut, M., Jung, J., Leboeuf, F.: Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes: Part I: Micronization of neat particles. Int. J. Pharm. 288, 3-10 (2005).
5. 2 solution. Chem. Pharm. Bull. 53, 1025-1028 (2005).
6. Al-Marzouqi, A.H., Shehatta, I., Jobe, B., Dowaidar, A.: Phase solubility and inclusion complex of itraconazole with - cyclodextrin using supercritical carbon dioxide. J. Pharm. Sci. 95, 292-304 (2006).
7. Uekama, K.: Design and evaluation of cyclodextrin-based drug formulation. Chem. Pharm. Bull. 52, 900-915 (2004).
8. Loftsson, T., Masson, M., Brewster, M.E.: Self-association of cyclodextrins and cyclodextrin complexes. J. Pharm. Sci. 93, 1091-1099 (2004).
9. Challa, R., Ahuja, A., Ali, J., Khar, R.K.: Cyclodextrins in drug delivery: An updated review. AAPS Pharm. Sci. Tech. 6, E329-E357 (2005).
10. Zingone, G., Rubessa, F.: Preformulation study of the inclusion complex warfarin-β-cyclodextrin. Int. J. Pharm. 291, 3-10 (2005).
11. Sætern, A.M., Nguyen, N.B., Brandl, A.B., Brandl, M.: Effect of hydroxypropyl-β-cyclodextrin-complexation and pH on solubility of camptothecin. Int. J. Pharm. 284, 61-68 (2004).
12. Oda, M., Saitoh, H., Kobayashi, M., Aungs, B.J.: β-Cyclodextrin as a suitable solubilizing agent for in situ absorption study of poorly water-soluble drugs. Int. J. Pharm. 284, 95-102 (2004).
13. Wongmekiat, A., Yoshimatsu, S., Tozuka, Y., Moribe, K., Yamamoto, K.: Investigation of drug nanoparticle formation by co-grinding with cyclodextrins: Studies for indomethacin, furosemide and naproxen. J. Incl. Phenom. Macrocyc. Chem. 56, 29-32 (2006).
14. 2 system from rapid expansion of supercritical solutions (RESS): A mathematical model. Powder Technol. 154, 83-94 (2005).
15. Tozuka, Y., Fujito, T., Moribe, K., Yamamoto, K.: Ibuprofen-cyclodextrin inclusion complex formation using supercritical carbon dioxide. J. Incl. Phenom. Macrocyc. Chem. 56, 33-37 (2006).
16. Gurdial, G.S., Foster, N.R.: Solubility of o-hydroxybenzoic acid in supercritical carbon dioxide. Ind. Eng. Chem. Res. 30, 575-580 (1991).
17. Sasaki, T., Meguro, Y., Yoshida, Z.: Spectrophotometric measurement of uranium(VI)-tributylphosphate complex in supercritical carbon dioxide. Talanta 46, 689-695 (1998).